Hematogones were initially described as mysterious cells in bone marrow smears more than
70 years ago. These cells are normal bone marrow B-lymphocyte precursors with properties …

Options to pre-emptively treat impending relapse of myelodysplastic syndromes (MDS) and
acute myeloid leukaemia (AML) after allogeneic haematopoietic stem cell transplantation …

Transient marrow expansion of normal B-cell precursors, termed hematogones, is
occasionally observed after hematopoietic stem cell transplantation (HSCT). To understand …

Background Recent studies have demonstrated hematogones (HGs) expansion to be
associated with favorable outcomes in hematological diseases, especially in patients with …

Early after umbilical cord blood transplantation, patients show marked differences in bone
marrow (BM) hematogone percentages. Little is known about whether these differences are …

Introduction While the role of the immune system in altering and modulating the progression
of solid tumors is well studied, the impact of the immune system on the outcome and …

Benign precursors of B lymphocytes, termed hematogones, are observed in the regenerative
state of hematopoiesis following chemotherapy or allogeneic hematopoietic stem cell …

Hematogones are normal B-lineage lymphoid precursors in the bone marrow. B
lymphoblasts are immature neoplastic cells present in patients with precursor B-cell acute …

Increased levels of normal B cell precursors, termed hematogones (HGs), are observed in
regenerating bone marrow after chemotherapy or hematopoietic stem cell transplantation …

Purpose Hematopoietic stem cell transplantation (HSCT) offers new hope for improving the
outcome of leukemic patients who have failed chemotherapy or irradiation therapy. To our …